Individualized treatment strategies for chronic hepatitis B
Fan, R.; Hou, J.-l.; Sun, J.
Zhonghua Nei Ke Za Zhi 51(10): 746-748
2012
ISSN/ISBN: 0578-1426 PMID: 23290967 Document Number: 657197
Document emailed within 1 workday
Related Documents
Gómez Camacho, F.; Poyato González, A.; Vignote Alguacil, M.L.; de La Mata García, M.; González Fernández, R.A.; López Rubio, F.; Marchal Molina, T.; Miño Fugarolas, G. 1996: Comparison of 2 treatment strategies with prednisone and interferon in chronic hepatitis B Revista Espanola de Enfermedades Digestivas: Organo Oficial de la Sociedad Espanola de Patologia Digestiva 88(3): 185-190Lobello, S.; Lorenzoni, U.; Vian, A.; Floreani, A.; Brunetto, M.R.; Chiaramonte, M. 1998: Interferon treatment in hepatitis B surface antigen-positive hepatitis B e antibody-positive chronic hepatitis B: role of hepatitis B core antibody IgM titre in patient selection and treatment monitoring Journal of Viral Hepatitis 5(1): 61-66
Muñoz, A.E. 2007: New strategies for a better use of peginterferon and ribavirin and new drugs with specifically-targeted antiviral therapy for chronic hepatitis C Acta Gastroenterologica Latinoamericana 37(2): 126-133
Baba, T.; Makino, R.; Shibata, M.; Harada, E.; Mitamura, K. 1997: Interferon treatment for hepatitis G virus infection in patients with chronic hepatitis C Nihon Rinsho. Japanese Journal of Clinical Medicine 55(3): 625-630
Teuber, G.; Dienes, H.P.; Meyer zum Büschenfelde, K.H.; Gerken, G. 1995: Hepatitis B virus superinfection in a patient with chronic hepatitis C receiving alpha-interferon treatment Hepato-Gastroenterology 42(2): 189-191
Xu, J.-h.; Yu, Y.-y.; Si, C.-w.; Chen, X.-y.; Han, Z.-h.; Chen, Y.; Li, X.-y. 2009: A clinical study of viral dynamic change in patients with hepatitis B e antigen positive chronic hepatitis B by lamivudine treatment Zhonghua Yi Xue Za Zhi 89(41): 2902-2905
Armignacco, O.; Andreoni, M.; Sagnelli, E.; Puoti, M.; Bruno, R.; Gaeta, G.Battista.; Perno, C.F.; Santantonio, T.A.; Bonfanti, P.; Bonora, S.; Borderi, M.; Castagna, A.; d'Arminio Monforte, A.; De Luca, A.; Grossi, P.; Guaraldi, G.; Maggiolo, F.; Mussini, C.; Sagnelli, C.; Tavio, M.; Torti, C.; Uberti-Foppa, C.; Andreoni, M.; Angarano, G.; Antinori, A.; Armignacco, O.; Carosi, G.; Chirianni, A.; Di Perri, G.; Galli, M.; Lazzarin, A.; Rizzardini, G.; Sagnelli, E.; Taliani, G. 2014: Recommendations for the use of hepatitis C virus protease inhibitors for the treatment of chronic hepatitis C in HIV-infected persons. A position paper of the Italian Association for the Study of Infectious and Tropical Disease new microbiologica 37(4): 423-438
Succi, L.; Oliveri, C.E.; Privitera, A.C.; Randazzo, G.; Ohazuruike, N.L.; Prumeri, S.; Politi, A. 2008: Treatment strategies for chronic constipation: our experience Chirurgia Italiana 60(4): 509-518
Desenclos, J.C.; Dubois, F.; Mariotte, N.; Goudeau, A. 1997: Should hepatitis C be screened? Analysis of oriented screening strategies for hepatitis C virus infection Gastroenterologie Clinique et Biologique 21(1 Part 2): S25-S32
Zhang, S.X. 1992: Chinese strategies for hepatitis B virus markers screening in hepatitis B vaccination based on cost-effectiveness analysis Zhonghua Yu Fang Yi Xue Za Zhi 26(3): 154-158
Salvemini, D. 2010: Searching for new strategies for the pharmacological treatment of chronic pain Missouri Medicine 107(4): 262-264
Tung, H.-D.; Lu, S.-N.; Lee, C.-M.; Wang, J.-H.; Chen, T.-M.; Hung, C.-H.; Huang, W.-S.; Changchien, C.-S. 2002: Antiviral treatment responses in patients with chronic hepatitis C virus infection evaluated by a third generation anti-hepatitis C virus assay Journal of Viral Hepatitis 9(4): 304-308
Hrycewycz, N.; Sandres, K.; Barange, K.; Pascal, J.P.; Izopet, J.; Payen, J.L. 2001: Eradication of hepatitis C virus after 3 months of interferon and ribavirin treatment in an a interferon non-responder patient with chronic hepatitis C Gastroenterologie Clinique et Biologique 25(11): 1041-1042
Pirotte, J.; Rauber, G.; Ruyters, L. 1972: Chronic persistent hepatitis and chronic active hepatitis. Correlations between the histological aspects, clinical picture, biological and immunological data Archives Francaises des Maladies de l'Appareil Digestif 61(1): 7-18
Sonnabend, W.; Kistler, G.S.; Thiel, G.; Zollinger, H.U.; Bianchi, L.; Enderlin, F.; Gudat, F.; Krech, U. 1974: Chronic focal glomerulonephritis and chronic persistent hepatitis following kidney transplantation. Detection of Hepatitis B and Epstein-Barr virus antigen Schweizerische Medizinische Wochenschrift 104(35): 1205-1217
Rohlffs, F.; Tsilimparis, N.; Diener, H.; Larena-Avellaneda, A.; Von Kodolitsch, Y.; Wipper, S.; Debus, E.S.; Kölbel, T. 2015: Chronic type B aortic dissection: indications and strategies for treatment Journal of Cardiovascular Surgery 56(2): 231-238
Korba, B.E.; Cote, P.J.; Menne, S.; Toshkov, I.; Baldwin, B.H.; Wells, F.V.; Tennant, B.C.; Gerin, J.L. 2004: Clevudine therapy with vaccine inhibits progression of chronic hepatitis and delays onset of hepatocellular carcinoma in chronic woodchuck hepatitis virus infection Antiviral Therapy 9(6): 937-952
Viron, B.; Michel, C.; Mignon, F. 1991: Different strategies of substitute treatment of end-stage chronic kidney failure by dialysis La Revue du Praticien 41(12): 1050-1054
Patiakina, O.K.; Garov, E.V. 1998: Strategies for the treatment of labyrinthine fistula in chronic purulent otitis media with cholesteatoma Vestnik Otorinolaringologii 1: 6-9
Gallagher, R.M. 2005: Rational integration of pharmacologic, behavioral, and rehabilitation strategies in the treatment of chronic pain American Journal of Physical Medicine and Rehabilitation 84(3 Suppl): S64-S76